Uflex Reports Strong Q4 FY26 with Record Margins

Consolidated revenue for Q4 FY26 reached ₹4,097.3 crore, a 12.8% sequential increase. Consolidated EBITDA surged to ₹626.5 crore, up 36.3% sequentially and 31.8% year-on-year. The EBITDA margin expanded to a 14-quarter high of 15.3%.

Reader Takeaway: Margin expansion driven by product mix; capacity expansion to fuel FY27 growth.

What just happened

Uflex Limited announced its Q4 FY26 financial results, showcasing significant sequential growth in both revenue and profitability. The company achieved consolidated revenue of ₹4,097.3 crore and EBITDA of ₹626.5 crore. Key to the results was the expansion of the EBITDA margin to 15.3%, the highest in 14 quarters, attributed to better product mix and improved realizations.

Why this matters

This performance indicates strong operational leverage and the company's ability to enhance profitability. The strategic focus on higher-margin packaging solutions and capacity expansions are crucial for future growth and shareholder value. The strong EBITDA growth, outpacing revenue growth, suggests improved operational efficiency.

The backstory

For the full fiscal year FY26, Uflex reported consolidated revenue of ₹15,513 crore and EBITDA of ₹1,983.6 crore, with an annual EBITDA margin of 12.8%. The packaging films segment faced challenges with a 1% volume decline for the full year due to macroeconomic and tariff issues, while packaging solutions, particularly aseptic packaging, showed resilience and growth.

What changes now

Several strategic capital expenditure projects are nearing completion, including aseptic packaging in Egypt (H1 FY27), a WPP facility in Mexico (near commissioning), and a BOPP line in Dharwad (FY27-28). A recycling facility has already been commissioned. These are expected to drive growth in FY27 and beyond.

Risks to watch

Management cautioned that the high Q4 EBITDA margins, particularly for the films segment, were boosted by temporary abnormal market spreads which have now moderated. Investors should not expect these peak margins to be sustained. Additionally, ongoing public interest litigation in some states regarding aseptic packaging for liquor is being monitored.

Peer comparison

While direct peer performance data for Q4 FY26 is not provided in the filing, Uflex's reported margin expansion and focus on value-added packaging solutions indicate a strategic differentiation. The company aims to increase the contribution of packaging solutions, which currently represent about 40% of EBITDA, to improve overall profitability.

Context metrics (time-bound)

Consolidated Revenue (Q4 FY26): ₹4,097.3 crore (+12.8% seq).
Consolidated EBITDA (Q4 FY26): ₹626.5 crore (+36.3% seq).
EBITDA Margin (Q4 FY26): 15.3% (14-quarter high).
Packaging Films Volume (FY26): 498,034 MT (-1% YoY).
Aseptic Packaging Volume (FY26): 7.97 billion packs (+2.4% YoY).
Capital Expenditure (FY27 projection): ₹1,900-2,000 crore.

What to track next

Investors will be keen to observe the ramp-up of new capacities, especially the aseptic packaging unit in Egypt. Monitoring the sustainability of EBITDA margins as market spreads normalize and tracking developments in the regulatory landscape for aseptic packaging will be crucial.